UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000001141
Receipt No. R000001385
Scientific Title Phase I Study of gemtuzumab ozogamicin in combination with cytarabinne and daunorubicin as induction therapy for relapsed or refractory patients with acute myeloid leukemia.
Date of disclosure of the study information 2008/05/10
Last modified on 2011/10/31 16:00:38

No. Disposal Last modified on Item of update
1 Insert 2008/04/30 18:31:20
2 Update 2009/10/30 15:19:30 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
3 Update 2010/05/14 18:27:04 Date analysis concluded
4 Update 2011/10/31 16:00:38 Recruitment status
Date analysis concluded
Publication of results
URL related to results and publications
Results
Results


Contact us.